Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5598 USD | +2.41% |
|
-0.04% | -64.34% |
Financials (USD)
Sales 2024 * | 17.57M | Sales 2025 * | 29.87M | Capitalization | 48.28M |
---|---|---|---|---|---|
Net income 2024 * | -35M | Net income 2025 * | -16M | EV / Sales 2024 * | 2.75 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.62 x |
P/E ratio 2024 * |
-2.01
x | P/E ratio 2025 * |
-
| Employees | 79 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 100% |
Latest transcript on BioLineRx Ltd.
1 day | +2.41% | ||
1 week | -0.04% | ||
Current month | -1.77% | ||
1 month | -14.87% | ||
3 months | -26.49% | ||
6 months | -64.00% | ||
Current year | -64.34% |
![Extreme 0.51](/images/extremecours_fleche.png)
![Extreme 0.51](/images/extremecours_fleche.png)
![Extreme 0.51](/images/extremecours_fleche.png)
![Extreme 0.51](/images/extremecours_fleche.png)
![Extreme 0.51](/images/extremecours_fleche.png)
![Extreme 0.51](/images/extremecours_fleche.png)
![Extreme 0.51](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Philip Serlin
CEO | Chief Executive Officer | 63 | 09-05-23 |
Mali Zeevi
DFI | Director of Finance/CFO | 48 | 08-12-31 |
Irit Gliko-Kabir
CTO | Chief Tech/Sci/R&D Officer | - | 17-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sandra Panem
BRD | Director/Board Member | 77 | 14-02-23 |
Avraham Molcho
BRD | Director/Board Member | 66 | 09-12-31 |
Aharon Schwartz
CHM | Chairman | 80 | 03-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-08 | 0.5598 | +2.41% | 155,782 |
24-07-05 | 0.5466 | +3.15% | 360,762 |
24-07-03 | 0.5299 | -0.39% | 299,438 |
24-07-02 | 0.532 | -5.00% | 394,082 |
Delayed Quote Nasdaq, July 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.43% | 124B | |
+19.81% | 114B | |
-23.74% | 19.42B | |
-18.24% | 16.2B | |
-19.97% | 15.31B | |
-49.33% | 14.19B | |
+57.08% | 14.32B | |
+7.95% | 14.31B | |
+126.04% | 11.29B |
- Stock Market
- Equities
- BLRX Stock
- BLRX Stock